Nova Mentis Life Science Corp (NOVA.CN) WACC Analysis

As of May 22, 2025, Nova Mentis Life Science Corp (NOVA.CN) carries a Weighted Average Cost of Capital (WACC) of 7.4%. WACC reflects the blended rate Nova Mentis Life Science Corp must pay to both equity and debt holders.

Within that, the cost of equity is 9.6%, the cost of debt is 5.0%, and the effective tax rate is 25.9%.

Breakdown of WACC Components

• Long-term bond rate: 3.2% – 3.7%
• Equity market risk premium: 5.1% – 6.1%
• Adjusted beta: 1.27 – 1.37
• Additional risk adjustment: 0.0% – 0.5%
• Debt-to-equity ratio: 1

What It Means for Investors

With a selected WACC of 7.4%, Nova Mentis Life Science Corp must ensure any new investment returns exceed this threshold to generate shareholder value. This level reflects an attractive low cost of capital.